Key facts
- This page summarizes Kiu Cu Seng's Form 3 filing for Cyclacel Pharmaceuticals, Inc. (CYCC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2025, 11:31.
Kiu Cu Seng - 26 Feb 2025 Form 3 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)
- Reporting relationship
- CFO and Secretary, Director
- Issuer ticker
- CYCC
- Reported as of
- 26 Feb 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Feb 2025, 11:31:09 UTC
- Prior SEC filing
- 17 Nov 2021
- Next SEC filing
- 13 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kiu Cu Seng
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kiu Cu Seng filed Form 3 for Cyclacel Pharmaceuticals, Inc. (CYCC) on 28 Feb 2025.
Change
- Previous filing in this sequence was filed on 17 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYCC
holding
No Securities Beneficially Owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 26 Feb 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.